Detecting actionable mutations from matched plasma-based versus tissue next-generation sequencing in advanced non-small cell lung cancer: a retrospective single centre analysis on site

Abstract Background Liquid biopsies (LB) are used increasingly to detect actionable mutations in patients newly diagnosed with advanced non-small cell lung cancer (aNSCLC), though tissue biopsies (TB) still remain the gold standard. The value of systematically combining LB and TB next-generation seq...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christophe Bontoux, Caroline Lacoux, Jonathan Benzaquen, Jacques Boutros, Guylène Rignol, Elodie Long-Mira, Sandra Lassalle, Maryline Allegra, Doriane Bohly, Mathieu Garcia, Christelle Bonnetaud, Olivier Bordone, Jean-Marc Félix, Virginie Lespinet-Fabre, Virginie Tanga, Charles-Hugo Marquette, Valérie Taly, Aurélia Baurès, Simon Heeke, Marius Ilié, Véronique Hofman, Paul Hofman
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Series:	Journal of Experimental & Clinical Cancer Research
Subjects:	Liquid biopsy CtDNA NGS Methylation Non-small cell lung carcinoma Actionable genomic alterations
Online Access:	https://doi.org/10.1186/s13046-025-03480-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Detecting actionable mutations from matched plasma-based versus tissue next-generation sequencing in advanced non-small cell lung cancer: a retrospective single centre analysis on site

Similar Items